secwatch.observer — SEC 8-K summary
======================================

Issuer:     Limitless X Holdings Inc. (LIMX)
CIK:        0001803977
Form:       8-K
Filed at:   2022-05-26T23:59:59+00:00
Accession:  0001065949-22-000075
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 2.01, 3.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio Lab Naturals completes acquisition of LimitlessX, issuing 97 million shares
-------------------------------------------------------------------------------

- Issued 97 million shares to LimitlessX shareholders on May 20, 2022, with additional 9 million due within six months.
- Jaspreet Mathur, founder of LimitlessX, becomes controlling shareholder with 67% common stock and Class A preferred shares.
- Four directors resigned at closing: W. Edward Nichols, Darrell Avey, Jeremy Ostler, and Calvin D. Smiley, Sr.
- Entered four consulting agreements, issuing 1 million restricted shares to consultants for six-month services.
- LimitlessX holds exclusive manufacturing and distribution licenses for Divatrim, Smilz, Amarose, and LPI brands.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1803977/000106594922000075/0001065949-22-000075-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1803977/000106594922000075/blab8kmay252022v9.htm
  HTML page:      https://secwatch.observer/filing/0001065949-22-000075

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer